This book provides a comprehensive overview of the biosimilar regulatory framework, the development process and clinical aspects for development of biosimilars.

"After 18 years since the first biosimilar was approved, a lot has changed, from the regulatory guidelines to the stakeholder perceptions about the safety and e

Provides an update on the status of biosimilars and a perspective for the next decade. How biosimilars are developed in the future will include many AI-based fe

After 18 years since the first biosimilar was approved, a lot has changed, from the regulatory guidelines to the stakeholder perceptions about the safety and ef

Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and pat